Campbell Deegan Wealth Management’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$758K Sell
2,986
-10
-0.3% -$2.33K 0.54% 16
2026
Q1
$732K Buy
2,996
+6
+0.2% +$1.4K 0.59% 16
2025
Q4
$619K Buy
2,990
+48
+2% +$9.49K 0.5% 20
2025
Q3
$545K Buy
2,942
+5
+0.2% +$857 0.49% 19
2025
Q2
$449K Sell
2,937
-433
-13% -$66.6K 0.44% 19
2025
Q1
$559K Sell
3,370
-283
-8% -$44.3K 0.64% 14
2024
Q4
$528K Buy
+3,653
New +$566K 0.63% 19

Other funds holding JNJ

Campbell Deegan Wealth Management's JNJ Position: Q2 2026 in Review

Campbell Deegan Wealth Management reduced its Johnson & Johnson (JNJ) stake by 0.33% in Q2 2026, selling an estimated $2.33K and leaving 2,986 shares worth $758K. The position accounts for 0.54% of the portfolio, ranked #16.

Campbell Deegan Wealth Management first reported a position in JNJ in Q4 2024 and has held it in 7 quarters since. 4,677 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Campbell Deegan Wealth Management held 2,986 shares of Johnson & Johnson worth $758K as of Q2 2026.
  • Campbell Deegan Wealth Management sold 10 Johnson & Johnson shares in Q2 2026, an estimated $2.33K.
  • Johnson & Johnson made up 0.54% of Campbell Deegan Wealth Management's portfolio in Q2 2026, its #16 holding.
  • Campbell Deegan Wealth Management first reported a position in Johnson & Johnson in Q4 2024 and has held it in 7 quarters since.
  • 4,677 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Campbell Deegan Wealth Management's 13F filing for Q2 2026, filed 4 Aug 2026.